collection
https://read.qxmd.com/read/31203254/oral-anticoagulants-in-atrial-fibrillation-with-valvular-heart-disease-and-bioprosthetic-heart-valves
#21
JOURNAL ARTICLE
Aaqib H Malik, Srikanth Yandrapalli, Wilbert S Aronow, Julio A Panza, Howard A Cooper
OBJECTIVE: Current guidelines endorse the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF). However, little is known about their safety and efficacy in valvular heart disease (VHD). Similarly, there is a paucity of data regarding NOACs use in patients with a bioprosthetic heart valve (BPHV). We, therefore, performed a network meta-analysis in the subgroups of VHD and meta-analysis in patients with a BPHV. METHODS: PubMed, Cochrane and Embase were searched for randomised controlled trials...
September 2019: Heart
https://read.qxmd.com/read/30747965/association-of-left-ventricular-ejection-fraction-and-symptoms-with-mortality-after-elective-noncardiac-surgery-among-patients-with-heart-failure
#22
JOURNAL ARTICLE
Benjamin J Lerman, Rita A Popat, Themistocles L Assimes, Paul A Heidenreich, Sherry M Wren
Importance: Heart failure is an established risk factor for postoperative mortality, but how left ventricular ejection fraction and heart failure symptoms affect surgical outcomes is not fully described. Objectives: To determine the risk of postoperative mortality among patients with heart failure at various levels of echocardiographic (left ventricular systolic dysfunction) and clinical (symptoms) severity compared with those without heart failure and to evaluate how risk varies across levels of surgical complexity...
February 12, 2019: JAMA
https://read.qxmd.com/read/31179786/efficacy-of-ceftriaxone-1-g-daily-versus-2-g-daily-for-the-treatment-of-community-acquired-pneumonia-a-systematic-review-with-meta-analysis
#23
COMPARATIVE STUDY
João Paulo Telles, Juliette Cieslinski, Juliano Gasparetto, Felipe Francisco Tuon
Introduction : Ceftriaxone has been recommended as a first-line treatment for various infections; however, the doses for pneumonia have not been a consensus in randomized clinical trials. To compare ceftriaxone 1 g daily efficacy to other ceftriaxone dosing regimens in community-acquired pneumonia. Area covered : We performed a systematic review and meta-analysis on PubMed, Web of Science, Scopus, and LILACS. Randomized controlled trials of ceftriaxone in community-acquired pneumonia were included. Outcomes included clinical cure in modified intention-to-treatment, clinically and microbiologically evaluable patients...
July 2019: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/30860029/heart-failure-drug-treatment
#24
REVIEW
Patrick Rossignol, Adrian F Hernandez, Scott D Solomon, Faiez Zannad
Heart failure is the most common cardiovascular reason for hospital admission for people older than 60 years of age. Few areas in medicine have progressed as remarkably as heart failure treatment over the past three decades. However, progress has been consistent only for chronic heart failure with reduced ejection fraction. In acutely decompensated heart failure and heart failure with preserved ejection fraction, none of the treatments tested to date have been definitively proven to improve survival. Delaying or preventing heart failure has become increasingly important in patients who are prone to heart failure...
March 9, 2019: Lancet
https://read.qxmd.com/read/30923934/the-etiology-of-bell-s-palsy-a-review
#25
REVIEW
Wenjuan Zhang, Lei Xu, Tingting Luo, Feng Wu, Bin Zhao, Xianqi Li
Bell's palsy is the most common condition involving a rapid and unilateral onset of peripheral paresis/paralysis of the seventh cranial nerve. It affects 11.5-53.3 per 100,000 individuals a year across different populations. Bell's palsy is a health issue causing concern and has an extremely negative effect on both patients and their families. Therefore, diagnosis and prompt cause determination are key for early treatment. However, the etiology of Bell's palsy is unclear, and this affects its treatment. Thus, it is critical to determine the causes of Bell's palsy so that targeted treatment approaches can be developed and employed...
July 2020: Journal of Neurology
https://read.qxmd.com/read/30779651/management-of-cardiovascular-disease-in-women-with-breast-cancer
#26
REVIEW
Rachel Barish, Filipa Lynce, Keith Unger, Ana Barac
Cardio-oncology is a rapidly developing field which seeks to improve patient outcomes through enhanced clinical and research collaboration across the disciplines of oncology and cardiology. Breast cancer (BC) is the most common cancer diagnosis among women in the United States and, as decades of research have resulted in decreased mortality rates, there has been an increasing focus on reducing short- and long-term treatment toxicity and improving morbidity among survivors. Preexisting or emergent cardiovascular disease in a patient with BC requires a multidisciplinary, team-based approach to balance the need for curative cancer treatment while preventing increased cardiovascular disease morbidity and mortality...
February 19, 2019: Circulation
https://read.qxmd.com/read/30731372/heart-failure-and-adverse-heart-failure-outcomes-among-persons-living-with-hiv-in-a-us-tertiary-medical-center
#27
JOURNAL ARTICLE
Raza M Alvi, Maryam Afshar, Anne M Neilan, Noor Tariq, Malek Hassan, Jaime Gerber, Magid Awadalla, Connor P Mulligan, Adam Rokicki, Virginia A Triant, Markella V Zanni, Tomas G Neilan
BACKGROUND: Persons living with HIV (PLHIV) have an increased risk of heart failure (HF). However, little is known about outcomes among PLHIV with HF. The study aim was to compare HF outcomes among PLHIV with HF versus individuals without HIV with HF. METHODS: Our cohort included 2,308 individuals admitted with decompensated HF. We compared baseline characteristics, 30-day HF readmission, and cardiovascular (CV) and all-cause mortality. Within PLHIV, we assessed outcomes stratified between CD4 count and viral load (VL), and tested the association between traditional and HIV-specific parameters with 30-day HF readmission...
April 2019: American Heart Journal
https://read.qxmd.com/read/30776079/epidemiology-of-invasive-group-b-streptococcal-infections-among-nonpregnant-adults-in-the-united-states-2008-2016
#28
MULTICENTER STUDY
Louise K Francois Watkins, Lesley McGee, Stephanie J Schrag, Bernard Beall, Jennifer Hudson Jain, Tracy Pondo, Monica M Farley, Lee H Harrison, Shelley M Zansky, Joan Baumbach, Ruth Lynfield, Paula Snippes Vagnone, Lisa A Miller, William Schaffner, Ann R Thomas, James P Watt, Susan Petit, Gayle E Langley
IMPORTANCE: Group B Streptococcus (GBS) is an important cause of invasive bacterial disease. Previous studies have shown a substantial and increasing burden of GBS infections among nonpregnant adults, particularly older adults and those with underlying medical conditions. OBJECTIVE: To update trends of invasive GBS disease among US adults using population-based surveillance data. DESIGN, SETTING, AND PARTICIPANTS: In this population-based surveillance study, a case was defined as isolation of GBS from a sterile site between January 1, 2008, and December 31, 2016...
April 1, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/30705099/igg4-related-disease-what-a-hematologist-needs-to-know
#29
REVIEW
Luke Y C Chen, Andre Mattman, Michael A Seidman, Mollie N Carruthers
IgG4-related disease is a fibro-inflammatory condition that can affect nearly any organ system. Common presentations include major salivary and lacrimal gland enlargement, orbital disease, autoimmune pancreatitis, retroperitoneal fibrosis and tubulointerstitial nephritis. This review focuses on the hematologic manifestations of IgG4-related disease, including lymphadenopathy, eosinophilia, and polyclonal hypergammaglobulinemia. The disease can easily be missed by unsuspecting hematologists, as patients may present with clinical problems that mimic disorders such as multicentric Castleman disease, lymphoma, plasma cell neoplasms and hypereosinophilic syndromes...
March 2019: Haematologica
https://read.qxmd.com/read/30478708/caring-for-the-critically-ill-patients-over-80-a-narrative-review
#30
REVIEW
Bertrand Guidet, Helene Vallet, Jacques Boddaert, Dylan W de Lange, Alessandro Morandi, Guillaume Leblanc, Antonio Artigas, Hans Flaatten
BACKGROUND: There is currently no international recommendation for the admission or treatment of the critically ill older patients over 80 years of age in the intensive care unit (ICU), and there is no valid prognostic severity score that includes specific geriatric assessments. MAIN BODY: In this review, we report recent literature focusing on older critically ill patients in order to help physicians in the multiple-step decision-making process. It is unclear under what conditions older patients may benefit from ICU admission...
November 26, 2018: Annals of Intensive Care
https://read.qxmd.com/read/30565021/practical-guidance-on-the-use-of-sacubitril-valsartan-for-heart-failure
#31
REVIEW
Andrew J Sauer, Robert Cole, Brian C Jensen, Jay Pal, Nakul Sharma, Amin Yehya, Justin Vader
Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor (ARNI) that has been recommended in clinical practice guidelines to reduce morbidity and mortality in patients with chronic, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF). This review provides an overview of ARNI therapy, proposes strategies to improve the implementation of sacubitril/valsartan in clinical practice, and provides clinicians with evidence-based, practical guidance on the use of sacubitril/valsartan in patients with HFrEF...
March 2019: Heart Failure Reviews
https://read.qxmd.com/read/30694927/nonparaneoplastic-autoimmune-cerebellar-ataxias
#32
REVIEW
Bastien Joubert, Jerome Honnorat
PURPOSE OF REVIEW: The current review develops the clinical presentations of nonparaneoplastic autoimmune cerebellar ataxia (ACA) and analyzes the association with autoantibodies. RECENT FINDINGS: Emerging evidence suggests that autoimmunity is involved in a significant proportion of sporadic ataxia cases. Moreover, numerous autoantibodies have recently been described in association with sporadic cerebellar ataxia, improving diagnosis and patient categorization...
June 2019: Current Opinion in Neurology
https://read.qxmd.com/read/30686041/2019-aha-acc-hrs-focused-update-of-the-2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial-fibrillation-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice-guidelines-and-the-heart-rhythm
#33
REVIEW
Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie, Paul A Heidenreich, Katherine T Murray, Julie B Shea, Cynthia M Tracy, Clyde W Yancy
No abstract text is available yet for this article.
July 9, 2019: Circulation
https://read.qxmd.com/read/30606404/epidemiology-pathophysiology-and-management-of-hepatorenal-syndrome
#34
REVIEW
Ahmed Adel Amin, Eman Ibrahim Alabsawy, Rajiv Jalan, Andrew Davenport
Acute kidney injury (AKI) is a common presentation in patients with advanced cirrhosis hospitalized with acute decompensation. A new revised classification now divides AKI in cirrhotic patients into two broad subgroups: hepatorenal syndrome AKI (HRS AKI) and non-hepatorenal syndrome AKI (non-HRS AKI). HRS AKI represents the end-stage complication of decompensated cirrhosis with severe portal hypertension and is characterized by worsening of renal function in the absence of prerenal azotemia, nephrotoxicity, and intrinsic renal disease...
January 2019: Seminars in Nephrology
https://read.qxmd.com/read/30659245/neuropsychiatric-lupus-new-mechanistic-insights-and-future-treatment-directions
#35
REVIEW
Noa Schwartz, Ariel D Stock, Chaim Putterman
Patients with systemic lupus erythematosus (SLE) frequently show symptoms of central nervous system (CNS) involvement, termed neuropsychiatric SLE (NPSLE). The CNS manifestations of SLE are diverse and have a broad spectrum of severity and prognostic implications. Patients with NPSLE typically present with nonspecific symptoms, such as headache and cognitive impairment, but might also experience devastating features, such as memory loss, seizures and stroke. Some features of NPSLE, in particular those related to coagulopathy, have been characterized and an evidence-based treatment algorithm is available...
March 2019: Nature Reviews. Rheumatology
https://read.qxmd.com/read/30596879/rheumatoid-arthritis
#36
REVIEW
Jeffrey A Sparks
Rheumatoid arthritis (RA) is a common systemic inflammatory autoimmune disease characterized by painful, swollen joints that can severely impair physical function and quality of life. The presenting symptoms of musculoskeletal pain, swelling, and stiffness are common in clinical practice, so familiarity with diagnosing and managing RA is crucial. Patients with RA are at greater risk for serious infection, respiratory disease, osteoporosis, cardiovascular disease, cancer, and mortality than the general population...
January 1, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/30578256/how-i-treat-low-von-willebrand-factor-levels
#37
REVIEW
Michelle Lavin, James S O'Donnell
Partial quantitative deficiency of plasma von Willebrand factor (VWF) is responsible for the majority of cases of von Willebrand disease (VWD), the most common inherited human bleeding disorder. International consensus guidelines recommend that patients with reduced plasma VWF antigen (VWF:Ag) levels and bleeding phenotypes be considered in 2 distinct subsets. First, patients with marked reductions in plasma VWF levels (<30 IU/dL) usually have significant bleeding phenotypes and should be classified with "type 1 VWD...
February 21, 2019: Blood
https://read.qxmd.com/read/30233481/systematic-review-syndromes-early-diagnosis-and-treatment-in-autoimmune-encephalitis
#38
REVIEW
Christina Hermetter, Franz Fazekas, Sonja Hochmeister
In recent years, new antibodies have been discovered which mediate autoimmune encephalitis. This immunological response can be triggered by an infection or a tumor. Classical onconeuronal antibodies are directed against intracellular neuronal agents but recently, a novel group of antibodies to neuronal cell-surface and synaptic antigens associated with different CNS-syndromes, has been discovered. Interestingly, the syndromes in this group can be successfully treated with immunotherapy and frequently do not have underlying tumors...
2018: Frontiers in Neurology
https://read.qxmd.com/read/30582516/one-year-in-review-2018-beh%C3%A3-et-s-syndrome
#39
REVIEW
Gulen Hatemi, Emire Seyahi, Izzet Fresko, Rosaria Talarico, Vedat Hamuryudan
New epidemiologic studies from Poland, Jordan, Algeria, Taiwan and Korea highlight the geographic differences in incidence, prevalence and clinical features of Behçet's syndrome (BS). A study from Austria comparing clinical manifestations of their BS patients with different countries of origin suggest that environmental factors may be important in the disease phenotype of BS. New genetic association studies dealing with the innate and acquired aspects of BS prevailed during 2017 and novel susceptibility and regulatory factors were described...
2018: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/30291106/management-of-hyperglycemia-in-type-2-diabetes-2018-a-consensus-report-by-the-american-diabetes-association-ada-and-the-european-association-for-the-study-of-diabetes-easd
#40
JOURNAL ARTICLE
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults. A systematic evaluation of the literature since 2014 informed new recommendations. These include additional focus on lifestyle management and diabetes self-management education and support. For those with obesity, efforts targeting weight loss, including lifestyle, medication, and surgical interventions, are recommended...
December 2018: Diabetes Care
label_collection
label_collection
7798
2
3
2019-01-06 22:36:15
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.